High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Joby Aviation shares have been cut nearly in half over the past year, yet analysts are quietly upgrading their outlooks ahead of a catalyst window packed with international launches, defense contracts, and a pivotal earnings report that could reset the stock's trajectory.
Its straightforward business has long been lucrative.
Faster upgrades and more customers buying higher-priced devices are likely to be Apple's goals.
The next six months may be decisive for the biotech.
Bloom Energy's blockbuster quarterly results finally hit the market a day late, and a fresh Wall Street upgrade is pouring fuel on a rally that's pulling the entire fuel-cell sector along for the ride.
Shares of Microsoft (NASDAQ:MSFT) are up 9% in early Thursday trading, changing hands at $427 after the software giant delivered a fiscal fourth-quarter blowout and crossed a symbolic Azure milestone. The pop lifts the stock off Wednesday’s $390.54 close and pushes it back toward levels last seen in the spring. As of yesterday’s close, Microsoft ... Microsoft Surges 9% as Azure Tops $100B and Q4 Beat Lifts Most Price Targets
AbbVie still looks like a compelling buy at its all-time high.
The AI chipmaker has 41 buy ratings. But the consensus target isn't much higher than the stock's price today.
A big bank just valued the rocket maker with a 2x Elon Musk premium baked in -- and still came up short of the IPO price.
Jeff Bezos still has control over space company Blue Origin -- just not 100% control.
The market just repriced the stock in a single session, leaving many analyst price targets significantly higher than the current stock price. Is it time for the stock to rebound?
One firm sees the memory maker nearly doubling. Another thinks it's already fully priced. The gap is the whole debate about this stock.
It's the last of the Big Four banks to declare a dividend raise this earnings season.
AMD Wins Fresh AI Vote of Confidence as Top Analysts Lift Price Targets
Tesla posted record deliveries and a massive revenue beat, yet watched $71 billion in market cap vanish overnight. What analysts are telling clients now about the road ahead reveals a striking split between the headline numbers and the real story inside the quarter.
Some Dividend Kings have quietly raised their payouts every single year for seven decades, yet most investors have never heard their names. Finding out which companies built that kind of streak reveals a lot about where durable income actually hides.
Marvell collapsed 34% from its June peak while reporting accelerating AI bookings and raising its full-year outlook, a contradiction that points to either a rare buying opportunity or a value trap hiding behind hypergrowth expectations.
Aflac increased its first-quarter dividend 5.2%, but investors need to watch more than the dividend with this unique insurance company.
Palantir bears have called the stock overvalued at every step, yet the company keeps silencing them with results that strain credibility. After eight straight earnings beats and a dramatic guidance raise, our model lands on a price target that may surprise both sides of the debate.
The company is developing a direct-to-device satellite internet business, but will face major hurdles if it is to be successful.
SpaceX's unique business model comes with a high ceiling, but also a low floor.
The chipmaker's stock has gotten way too overheated.
This industry-leading business can quench investors' thirst for a dependable income stream.
Palantir has cratered while AMD has gone parabolic, yet our model hands both the same rating and confidence score. The reasoning behind that call reveals a tension in AI investing that most price targets ignore.
Raymond James just slapped a jaw-dropping price target on SpaceX that implies a valuation larger than any company in history, and the bull case hinges on whether Elon Musk can pull off something that seems to defy the laws of physics.
Astera Labs, Inc. (NASDAQ:ALAB) is among the Best AI Stocks. On June 29, UBS raised its price target on Astera Labs, Inc. (NASDAQ:ALAB) to $400 from $205. The firm maintained a Neutral rating on the stock. Earlier, on June 3, Astera Labs, Inc. (NASDAQ:ALAB) announced an expansion of its Taiwan operations and Cloud-Scale Interop Lab. It […]
SpaceX spotlights everything that's currently amiss on Wall Street.
The dividend looks secure. The share price is the harder call.
It isn't just investors who are bullish about SpaceX; some analysts also have rosy outlooks for the business.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
